Literature DB >> 20863814

Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10.

Joanna Kim1, Sook Shin, Malayannan Subramaniam, Elizabeth Bruinsma, Tae-Dong Kim, John R Hawse, Thomas C Spelsberg, Ralf Janknecht.   

Abstract

JARID1B/KDM5B (jumonji AT-rich interactive domain 1B/lysine-specific demethylase 5B) is an enzyme that efficiently removes methyl residues from trimethylated lysine 4 on histone H3, a pivotal mark for active chromatin. TIEG1/KLF10 (transforming growth factor-β inducible early gene-1/Krüppel-like transcription factor 10) is a zinc-finger transcription factor that is involved in bone metabolism and exerts antiproliferative activity. Here, we found that TIEG1 interacts with JARID1B. In particular, the repression domains of TIEG1 bind to the C-terminus of JARID1B. Moreover, overexpression of JARID1B augments TIEG1 to repress transcription of Smad7, an inhibitor of the TGF-β (transforming growth factor-β) signaling pathway. Conversely, JARID1B knock-down leads to increased Smad7 mRNA levels. Thus, TIEG1 and JARID1B may cooperate to suppress tumorigenesis by enhancing TGF-β signaling. Notably, both TIEG1 and JARID1B are downregulated in melanomas, suggesting that they indeed cooperate physiologically. In conclusion, JARID1B is the first TIEG1 corepressor identified, explaining how TIEG1 represses transcription through inducing histone H3 lysine 4 demethylation, which may be important for TIEG1 function in both normal and cancer cells.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20863814      PMCID: PMC2963657          DOI: 10.1016/j.bbrc.2010.09.068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

1.  Kruppel-like factor KLF10 is a link between the circadian clock and metabolism in liver.

Authors:  Fabienne Guillaumond; Aline Gréchez-Cassiau; Malayannan Subramaniam; Sophie Brangolo; Brigitta Peteri-Brünback; Bart Staels; Catherine Fiévet; Thomas C Spelsberg; Franck Delaunay; Michèle Teboul
Journal:  Mol Cell Biol       Date:  2010-04-12       Impact factor: 4.272

2.  Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300.

Authors:  S Papoutsopoulou; R Janknecht
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

3.  PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen?

Authors:  Angela Barrett; Bente Madsen; John Copier; Pei Juan Lu; Lucienne Cooper; Angelo G Scibetta; Joy Burchell; Joyce Taylor-Papadimitriou
Journal:  Int J Cancer       Date:  2002-10-20       Impact factor: 7.396

4.  Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.

Authors:  Steven A Johnsen; Malayannan Subramaniam; Takenobu Katagiri; Ralf Janknecht; Thomas C Spelsberg
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

5.  Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu.

Authors:  Apollina Goel; Ralf Janknecht
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

6.  Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.

Authors:  Basem S Goueli; Ralf Janknecht
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

7.  HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81.

Authors:  Sean C Dowdy; Andrea Mariani; Ralf Janknecht
Journal:  J Biol Chem       Date:  2003-08-28       Impact factor: 5.157

8.  Regulation of the ER81 transcription factor and its coactivators by mitogen- and stress-activated protein kinase 1 (MSK1).

Authors:  Ralf Janknecht
Journal:  Oncogene       Date:  2003-02-06       Impact factor: 9.867

9.  Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A.

Authors:  Jianmin Wu; Ralf Janknecht
Journal:  J Biol Chem       Date:  2002-09-03       Impact factor: 5.157

10.  Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9.

Authors:  Keith Tan; Anthony L Shaw; Bente Madsen; Kirsten Jensen; Joyce Taylor-Papadimitriou; Paul S Freemont
Journal:  J Biol Chem       Date:  2003-03-25       Impact factor: 5.157

View more
  29 in total

Review 1.  JARID1 Histone Demethylases: Emerging Targets in Cancer.

Authors:  Kayla M Harmeyer; Nicole D Facompre; Meenhard Herlyn; Devraj Basu
Journal:  Trends Cancer       Date:  2017-09-12

2.  Krüppel-like Transcription Factor KLF10 Suppresses TGFβ-Induced Epithelial-to-Mesenchymal Transition via a Negative Feedback Mechanism.

Authors:  Vivek Kumar Mishra; Malayannan Subramaniam; Vijayalakshmi Kari; Kevin S Pitel; Simon J Baumgart; Ryan M Naylor; Sankari Nagarajan; Florian Wegwitz; Volker Ellenrieder; John R Hawse; Steven A Johnsen
Journal:  Cancer Res       Date:  2017-03-01       Impact factor: 12.701

3.  MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.

Authors:  X Cheng; Y Yang; Z Fan; L Yu; H Bai; B Zhou; X Wu; H Xu; M Fang; A Shen; Q Chen; Y Xu
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

4.  Transcription factors ER71/ETV2 and SOX9 participate in a positive feedback loop in fetal and adult mouse testis.

Authors:  Luciano DiTacchio; Josephine Bowles; Sook Shin; Dae-Sik Lim; Peter Koopman; Ralf Janknecht
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

5.  TGFβ2 regulates hypothalamic Trh expression through the TGFβ inducible early gene-1 (TIEG1) during fetal development.

Authors:  Miriam Martínez-Armenta; Sol Díaz de León-Guerrero; Ana Catalán; Lourdes Alvarez-Arellano; Rosa Maria Uribe; Malayannan Subramaniam; Jean-Louis Charli; Leonor Pérez-Martínez
Journal:  Mol Cell Endocrinol       Date:  2014-11-18       Impact factor: 4.102

6.  Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma.

Authors:  Fu-Yao Liu; Yue-Ling Deng; Yuan Li; Dan Zeng; Zhen-Zhen Zhou; De-An Tian; Mei Liu
Journal:  Med Oncol       Date:  2013-01-17       Impact factor: 3.064

7.  ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.

Authors:  Sook Shin; Sangphil Oh; Seayoon An; Ralf Janknecht
Journal:  Oncol Rep       Date:  2012-10-16       Impact factor: 3.906

8.  TIEG1 enhances Osterix expression and mediates its induction by TGFβ and BMP2 in osteoblasts.

Authors:  Malayannan Subramaniam; Kevin S Pitel; Sarah G Withers; Hicham Drissi; John R Hawse
Journal:  Biochem Biophys Res Commun       Date:  2016-01-20       Impact factor: 3.575

9.  Repression of myoblast proliferation and fibroblast growth factor receptor 1 promoter activity by KLF10 protein.

Authors:  Rajini Parakati; Joseph X DiMario
Journal:  J Biol Chem       Date:  2013-04-08       Impact factor: 5.157

10.  Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D.

Authors:  Tae-Dong Kim; Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.